Search
for
Sort by
Research 61–90 of 1000+
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Cutaneous manifestations of COVID-19 and vaccines for its prevention: a review of the existing literature
- Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents
- Clinico-Epidemiological Aspects of Cutaneous Lesions in Injecting Drug Users Visiting an Oral Substitution Therapy Centre: A Cross-Sectional Study
- Severe pityriasis rubra pilaris complicated with Kaposi's varicelliform eruption and cutaneous MRSA infection case report
- Faculty Opinions recommendation of Identification of drug-specific public TCR driving severe cutaneous adverse reactions.
- Novel Strategies for Androgenetic Alopecia Therapy: Integrating Multifunctional Plant Extracts with Nanotechnology for Advanced Cutaneous Drug Delivery
- Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
- Effets secondaires cutanéo-muqueux des nouvelles molécules anticancéreuses: Inhibiteurs de l'EGF-R, inhibiteurs de tyrosine kinase et stabilisateurs du fuseau mitotique
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Mucocutaneous reactions to chemotherapy
- Cutaneous manifestations of COVID-19: a systematic review and analysis of individual patient-level data
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Proposal for Clinical Classification of Cutaneous Manifestations in Covid-19 and in Post Vaccination Against Sars-Cov-2: An Observational Study
- Spectrum of mucocutaneous manifestations in human immunodeficiency virus-infected patients and its correlation with CD4 lymphocyte count
- Cutaneous manifestations associated with substance use disorders
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Dermatologic Problems of Older Women
- Topical imiquimod—Be aware of the unexpected
- Acne
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Adverse Cutaneous Reactions to Mood Stabilizers
- Self-Assessment
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- The Dermatological Spectrum of Coronavirus Disease-19 Disease: Cutaneous Signs for Diagnostics and Prognosis and an Expanded Classification
- Concurrence of Palmoplantar Psoriasiform Eruptions and Hair Loss during Carbamazepine Treatment
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Cutaneous complications of chemotherapeutic agents
- Lupus erythematosus: systemic and cutaneous manifestations